Canada Markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
66.94-0.04 (-0.06%)
At close: 4:00PM EST

66.53 -0.41 (-0.61%)
After hours: 6:31PM EST

Full screen
Trade prices are not sourced from all markets
Previous Close66.98
Open66.53
Bid66.95 x 900
Ask66.96 x 800
Day's Range66.26 - 67.47
52 Week Range56.56 - 85.97
Volume4,690,553
Avg. Volume9,987,724
Market Cap83.911B
Beta (5Y Monthly)0.53
PE Ratio (TTM)66.47
EPS (TTM)1.01
Earnings DateFeb. 04, 2021
Forward Dividend & Yield2.72 (4.06%)
Ex-Dividend DateDec. 14, 2020
1y Target Est72.85
  • Where Will Sorrento Therapeutics Be in 1 Year?
    Motley Fool

    Where Will Sorrento Therapeutics Be in 1 Year?

    Last year, Sorrento Therapeutics (NASDAQ: SRNE) became one of the hottest coronavirus stocks. The enormous volatility behind Sorrento stock is not without reason. After the development of its coronavirus tests and therapeutics began to stall, shareholders started ditching the company in favor of its competitors.

  • Gilead Sciences to Release Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 4, 2021
    Business Wire

    Gilead Sciences to Release Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 4, 2021

    Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2020 financial results will be released on Thursday, February 4, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s fourth quarter and full year 2020 financial results and will provide a business update.

  • Gilead (GILD) Up 19% in the Past Month: What Lies Ahead?
    Zacks

    Gilead (GILD) Up 19% in the Past Month: What Lies Ahead?

    Gilead (GILD) gains more than 19% in the past month and is poised to post a robust performance in the year ahead on strong HIV franchise.